Synapse Open Synapse
Biology

Eating disorders are on the rise. GLP-1s could make things worse.

MIT TR Biotechnology · · 5 min read

GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinical psychologists, they can represent something more sinister—a potential trigger for eating disorders.

Same story elsewhere

Latest from MIT TR Biotechnology